David Kevans

2.3k total citations · 1 hit paper
58 papers, 1.3k citations indexed

About

David Kevans is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, David Kevans has authored 58 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Genetics, 31 papers in Epidemiology and 23 papers in Surgery. Recurrent topics in David Kevans's work include Inflammatory Bowel Disease (35 papers), Microscopic Colitis (27 papers) and Helicobacter pylori-related gastroenterology studies (10 papers). David Kevans is often cited by papers focused on Inflammatory Bowel Disease (35 papers), Microscopic Colitis (27 papers) and Helicobacter pylori-related gastroenterology studies (10 papers). David Kevans collaborates with scholars based in Ireland, Canada and United States. David Kevans's co-authors include Mark S. Silverberg, Hugh Mulcahy, Diarmuid P. O’Donoghue, Jacintha O’Sullivan, Kieran Sheahan, John Hyland, Lai Mun Wang, Anne M. Griffiths, Andrew D. Paterson and D. Fennelly and has published in prestigious journals such as Nature Genetics, Gastroenterology and International Journal of Cancer.

In The Last Decade

David Kevans

55 papers receiving 1.2k citations

Hit Papers

Association of host genome with intestinal microbial comp... 2016 2026 2019 2022 2016 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Kevans Ireland 18 424 374 372 333 295 58 1.3k
Annamaria Pronio Italy 19 221 0.5× 420 1.1× 169 0.5× 271 0.8× 444 1.5× 53 1.2k
Jürgen Siebler Germany 16 304 0.7× 121 0.3× 380 1.0× 219 0.7× 217 0.7× 60 1.1k
Abdulrahman Aljebreen Saudi Arabia 19 157 0.4× 257 0.7× 187 0.5× 217 0.7× 478 1.6× 62 1.1k
Alexander C. von Roon United Kingdom 10 148 0.3× 409 1.1× 179 0.5× 314 0.9× 338 1.1× 15 861
Jens Kelsen Denmark 19 232 0.5× 539 1.4× 165 0.4× 445 1.3× 206 0.7× 48 1.4k
Klaudia Farkas Hungary 21 236 0.6× 784 2.1× 178 0.5× 594 1.8× 507 1.7× 155 1.5k
Federica Gaiani Italy 18 278 0.7× 110 0.3× 290 0.8× 110 0.3× 551 1.9× 61 1.2k
M. Herranz Spain 19 241 0.6× 119 0.3× 161 0.4× 197 0.6× 324 1.1× 64 1.3k
S Dattagupta India 21 441 1.0× 89 0.2× 221 0.6× 300 0.9× 378 1.3× 48 1.2k
Takahiro Kudo Japan 15 205 0.5× 400 1.1× 137 0.4× 198 0.6× 434 1.5× 106 1.2k

Countries citing papers authored by David Kevans

Since Specialization
Citations

This map shows the geographic impact of David Kevans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Kevans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Kevans more than expected).

Fields of papers citing papers by David Kevans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Kevans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Kevans. The network helps show where David Kevans may publish in the future.

Co-authorship network of co-authors of David Kevans

This figure shows the co-authorship network connecting the top 25 collaborators of David Kevans. A scholar is included among the top collaborators of David Kevans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Kevans. David Kevans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ryan, Anthony W., Emma M. Quinn, Ronán Conroy, et al.. (2025). P1300 HLA-C*06 Genotype and Ustekinumab Therapy Persistence in Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 19(Supplement_1). i2344–i2344.
2.
Slattery, Eoin, et al.. (2023). P695 Effectiveness and Safety of Combination Biologic or Small Molecule Therapy in Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 17(Supplement_1). i825–i826. 1 indexed citations
3.
McDonagh, P. F., et al.. (2023). P089 Colonic explant lactate concentration and inflammatory protein secretion in ulcerative colitis. Journal of Crohn s and Colitis. 17(Supplement_1). i251–i253. 1 indexed citations
4.
Ryan, Anthony W., et al.. (2023). P607 HLA-DQA1*05 Allele Carriage and Anti-TNF Therapy Persistence in Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 17(Supplement_1). i734–i735. 1 indexed citations
5.
O’Connell, Fiona, et al.. (2022). Association Between Ex Vivo Human Ulcerative Colitis Explant Protein Secretion Profiles and Disease Behaviour. Digestive Diseases and Sciences. 67(12). 5540–5550. 4 indexed citations
6.
Castro, Patricia Domínguez, Valerie Trimble, Deirdre McNamara, et al.. (2020). Prevalence of coexisting autoimmune thyroidal diseases in coeliac disease is decreasing. United European Gastroenterology Journal. 8(2). 148–156. 9 indexed citations
7.
O'Connell, J E A, Stephen Keohane, P. F. McDonagh, et al.. (2020). Characteristics and outcomes of acute colitis diagnosed on cross-sectional imaging presenting via the emergency department in an Irish academic medical centre. Irish Journal of Medical Science (1971 -). 189(3). 1115–1121. 1 indexed citations
8.
Smith, Sinéad M., Breida Boyle, Denise Brennan, et al.. (2017). The Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of H. pylori infection in adult patients in Ireland. European Journal of Gastroenterology & Hepatology. 29(5). 552–559. 27 indexed citations
9.
Fortinsky, Kyle J., David Kevans, Judy Qiang, et al.. (2016). Rates and Predictors of Endoscopic and Clinical Recurrence After Primary Ileocolic Resection for Crohn’s Disease. Digestive Diseases and Sciences. 62(1). 188–196. 12 indexed citations
10.
Kevans, David, et al.. (2016). Treatment of Clostridium difficile infection: a national survey of clinician recommendations and the use of faecal microbiota transplantation. Journal of Hospital Infection. 95(4). 438–441. 7 indexed citations
11.
Turpin, Williams, Osvaldo Espin‐Garcia, Wei Xu, et al.. (2016). Association of host genome with intestinal microbial composition in a large healthy cohort. Nature Genetics. 48(11). 1413–1417. 322 indexed citations breakdown →
12.
Kevans, David, Mark S. Silverberg, Anne M. Griffiths, et al.. (2015). IBD Genetic Risk Profile in Healthy First-Degree Relatives of Crohn’s Disease Patients. Journal of Crohn s and Colitis. 10(2). 209–215. 32 indexed citations
13.
Zanello, Galliano, David Kevans, Ashleigh Goethel, et al.. (2014). Genetics and Innate and Adaptive Immunity in IBD. Nestlé Nutrition Institute Workshop series. 79. 41–55. 18 indexed citations
14.
Sheridan, Juliette, Patrick Paul Walsh, David Kevans, et al.. (2014). Determinants of short- and long-term survival from colorectal cancer in very elderly patients. Journal of Geriatric Oncology. 5(4). 376–383. 13 indexed citations
15.
Kevans, David, Boyko Kabakchiev, Judy Qiang, et al.. (2014). Sa1234 RNA-Seq Derived Whole Blood Gene Expression Signature As a Biomarker for Differential Diagnosis and Intestinal Inflammation in Inflammatory Bowel Disease. Gastroenterology. 146(5). S–238. 1 indexed citations
16.
Canney, Aoife, David Kevans, Lai Mun Wang, et al.. (2012). Stage II colonic adenocarcinoma: a detailed study of pT4N0 with emphasis on peritoneal involvement and the role of tumour budding. Histopathology. 61(3). 488–496. 18 indexed citations
17.
Kevans, David, Miriam Tosetto, Kieran Sheahan, et al.. (2011). Clusterin and Chemotherapy Sensitivity Under Normoxic and Graded Hypoxic Conditions in Colorectal Cancer. Journal of Gastrointestinal Cancer. 43(2). 305–313. 7 indexed citations
18.
Kevans, David, et al.. (2010). Failed biliary access following needle knife fistulotomy: is repeat interval ERCP worthwhile?. Scandinavian Journal of Gastroenterology. 45(10). 1238–1241. 20 indexed citations
19.
Kevans, David, Susan Hopkins, N. Mahmud, et al.. (2007). Haematological support during peg‐interferon therapy for HCV‐infected haemophiliacs improves virological outcomes. Haemophilia. 13(5). 593–598. 7 indexed citations
20.
Kevans, David, Denise Keegan, Hugh Mulcahy, & Diarmuid P. O’Donoghue. (2006). Infliximab therapy in Crohn's disease: a pragmatic approach?. Alimentary Pharmacology & Therapeutics. 24(2). 351–359. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026